TY - JOUR T1 - Kinetics of the Tau PET Tracer <sup>18</sup>F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1535 LP - 1542 DO - 10.2967/jnumed.115.170027 VL - 57 IS - 10 AU - Sergey Shcherbinin AU - Adam J. Schwarz AU - Abhinay Joshi AU - Michael Navitsky AU - Matthew Flitter AU - William R. Shankle AU - Michael D. Devous, Sr. AU - Mark A. Mintun Y1 - 2016/10/01 UR - http://jnm.snmjournals.org/content/57/10/1535.abstract N2 - We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer 18F-AV-1451 in 19 subjects. Methods: Subjects were clinically diagnosed as 4 young cognitively normal, 5 old cognitively normal, 5 mild cognitive impairment, and 5 Alzheimer disease (AD). Kinetic modeling was performed using Logan graphical analysis with the cerebellum crus as a reference region. Voxelwise binding potential () and SUV ratio () images were compared. Results: In AD subjects, slower and spatially nonuniform clearance from cortical regions was observed as compared with the controls, which led to focal uptake and elevated retention in the imaging data from 80 to 100 min after injection. BP from the dynamic data from 0 to 100 min correlated strongly (R2 &gt; 0.86) with corresponding regional values. In the putamen, the observed kinetics (positive at the tracer delivery stage and plateauing time–SUVR curves for all diagnostic categories) may suggest either additional off-target binding or a second binding site with different kinetics. Conclusion: The kinetics of the 18F-AV-1451 tracer in cortical areas, as examined in this small group of subjects, differed by diagnostic stage. A delayed 80- to 100-min scan provided a reasonable substitute for a dynamic 0- to 100-min acquisition for cortical regions although other windows (e.g., 75–105 min) may be useful to evaluate. ER -